AU2178392A - Albuterol sulfate suspension aerosol formulations - Google Patents

Albuterol sulfate suspension aerosol formulations

Info

Publication number
AU2178392A
AU2178392A AU21783/92A AU2178392A AU2178392A AU 2178392 A AU2178392 A AU 2178392A AU 21783/92 A AU21783/92 A AU 21783/92A AU 2178392 A AU2178392 A AU 2178392A AU 2178392 A AU2178392 A AU 2178392A
Authority
AU
Australia
Prior art keywords
aerosol formulations
albuterol sulfate
suspension aerosol
sulfate suspension
albuterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21783/92A
Inventor
Robert A Moris
Robert K Schultz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
3M Co
Original Assignee
3M Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to US71379391A priority Critical
Priority to US713793 priority
Application filed by 3M Co filed Critical 3M Co
Publication of AU2178392A publication Critical patent/AU2178392A/en
Application status is Abandoned legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/007Pulmonary tract; Aromatherapy
    • A61K9/0073Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/008Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy comprising drug dissolved or suspended in liquid propellant for inhalation via a pressurized metered dose inhaler [MDI]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/13Amines
    • A61K31/135Amines having aromatic rings, e.g. ketamine, nortriptyline
AU21783/92A 1991-06-12 1992-06-02 Albuterol sulfate suspension aerosol formulations Abandoned AU2178392A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US71379391A true 1991-06-12 1991-06-12
US713793 1991-06-12

Publications (1)

Publication Number Publication Date
AU2178392A true AU2178392A (en) 1993-01-12

Family

ID=24867564

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21783/92A Abandoned AU2178392A (en) 1991-06-12 1992-06-02 Albuterol sulfate suspension aerosol formulations

Country Status (6)

Country Link
AU (1) AU2178392A (en)
IE (1) IE921851A1 (en)
IL (1) IL102141D0 (en)
MX (1) MX9202855A (en)
WO (1) WO1992022286A1 (en)
ZA (1) ZA9204206B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7101534B1 (en) 1991-12-18 2006-09-05 3M Innovative Properties Company Suspension aerosol formulations
AU675633B2 (en) * 1991-12-18 1997-02-13 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
US6054488A (en) * 1996-06-11 2000-04-25 3M Innovative Properties Company Medicinal aerosol formulations of formoterol
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US6451285B2 (en) 1998-06-19 2002-09-17 Baker Norton Pharmaceuticals, Inc. Suspension aerosol formulations containing formoterol fumarate and a fluoroalkane propellant
US6004537A (en) * 1998-12-18 1999-12-21 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes, budesonide and formoterol
US6290930B1 (en) 1998-12-18 2001-09-18 Baker Norton Pharmaceuticals, Inc. Pharmaceutical solution aerosol formulations containing fluoroalkanes and budesonide
GB0208742D0 (en) 2002-04-17 2002-05-29 Bradford Particle Design Ltd Particulate materials
PE09502004A1 (en) 2003-02-14 2005-01-01 Theravance Inc AS biphenyl derivatives adrenoceptor agonists SS2 and as antagonists of muscarinic
TW200510298A (en) 2003-06-13 2005-03-16 Theravance Inc Substituted pyrrolidine and related compounds
TWI341836B (en) 2004-03-11 2011-05-11 Theravance Inc Biphenyl compounds useful as muscarinic receptor antagonists
DE102006053374A1 (en) * 2006-02-09 2007-08-16 Boehringer Ingelheim Pharma Gmbh & Co. Kg Pharmaceutical formulation for aerosols with two or more active substances and at least one surface-active substance
KR20090129998A (en) 2007-02-11 2009-12-17 맵 파마슈티컬스, 인코포레이티드 Method of therapeutic administration of dhe to enable rapid relief of migraine while minimizing side effect profile
EP2077132A1 (en) 2008-01-02 2009-07-08 Boehringer Ingelheim Pharma GmbH & Co. KG Dispensing device, storage device and method for dispensing a formulation
CN102405044A (en) 2009-02-06 2012-04-04 南加利福尼亚大学 Therapeutic compositions comprising monoterpenes
US10011906B2 (en) 2009-03-31 2018-07-03 Beohringer Ingelheim International Gmbh Method for coating a surface of a component
EP2432531B1 (en) 2009-05-18 2019-03-06 Boehringer Ingelheim International GmbH Adapter, inhalation device and nebulizer
BR112012000890A2 (en) 2009-07-15 2017-10-31 Theravance Inc crystalline free base forms of a biphenyl compound
BR112012012475A8 (en) 2009-11-25 2016-10-04 Boehringer Ingelheim Int "nebulizer"
EP2504051B1 (en) 2009-11-25 2019-09-04 Boehringer Ingelheim International GmbH Nebulizer
US10016568B2 (en) 2009-11-25 2018-07-10 Boehringer Ingelheim International Gmbh Nebulizer
WO2011160932A1 (en) 2010-06-24 2011-12-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2883543B1 (en) 2010-08-27 2016-11-16 Neonc Technologies Inc. Pharmaceutical compositions comprising perillyl alcohol carbamates
WO2012083178A1 (en) 2010-12-17 2012-06-21 Neo Oncology Inc. Methods and devices for using isoperillyl alcohol
EP2694220A1 (en) 2011-04-01 2014-02-12 Boehringer Ingelheim International GmbH Medical device comprising a container
US9827384B2 (en) 2011-05-23 2017-11-28 Boehringer Ingelheim International Gmbh Nebulizer
WO2013152894A1 (en) 2012-04-13 2013-10-17 Boehringer Ingelheim International Gmbh Atomiser with coding means
TR201802725T4 (en) 2013-03-15 2018-03-21 Verona Pharma Plc Drug combination.
US9744313B2 (en) 2013-08-09 2017-08-29 Boehringer Ingelheim International Gmbh Nebulizer
EP2835146A1 (en) 2013-08-09 2015-02-11 Boehringer Ingelheim International GmbH Nebulizer with blocking mechanism
MX2016014402A (en) 2014-05-07 2017-01-20 Boehringer Ingelheim Int Nebulizer and container.
AU2015257878B2 (en) 2014-05-07 2019-08-08 Boehringer Ingelheim International Gmbh Container, nebulizer and use
WO2015199626A1 (en) * 2014-06-27 2015-12-30 World Medicine İlaç Sanayi Ve Ticaret Anonim Şirketi STABLE AEROSOL FORMULATIONS OF β2- ADRENERGIC AGONISTS

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations

Also Published As

Publication number Publication date
ZA9204206B (en) 1993-03-31
MX9202855A (en) 1992-12-01
WO1992022286A1 (en) 1992-12-23
IE921851A1 (en) 1992-12-16
IL102141D0 (en) 1993-01-14

Similar Documents

Publication Publication Date Title
AU680227B2 (en) Stabilized medicinal aerosol solution formulations
AU678403B2 (en) Disposable aerosol mask
AU677021B2 (en) Turf product
AU660952B2 (en) Aerosol medicaments
AU671924B2 (en) Hair spray formulations having increased clarity
AU639078B2 (en) Coated perfume particles
AU676867B2 (en) Herbicides
IL116460D0 (en) Aerosol drug formulations
AU2768892A (en) Paint ball
ZW2293A1 (en) Herbicides
AU4927996A (en) Butixocort aerosol formulations
AU4950993A (en) Combination of germicidal agents
HU9403396D0 (en) Pharmaceutical aerosol compositions
AU1576992A (en) Fragrance-emitting container
AU3600193A (en) Nucleozymes
AU3391693A (en) Sulfonamidocarboxamide
AU1084492A (en) Dispenser
AU3255593A (en) Dispenser
AU1247095A (en) Powder inhalator
AU684477B2 (en) Silicas
AU6917894A (en) Aerosol actuator
AU5045193A (en) Exhalation valve
AU6956994A (en) The intrapulmonary delivery of aerosolized aqueous formulations
EP0689423A1 (en) Aerosol formulation containing a diol-diacid derived dispersing aid
ZA9607887B (en) Aerosol compositions